AbbVie sues to tighten 340B patient definition, curb discount abuses

AbbVie, Inc. +0.38%

AbbVie, Inc.

ABBV

198.13

+0.38%

  • AbbVie filed a lawsuit seeking a court ruling on 340B program patient eligibility standards.
  • Litigation targets 1996 federal guidance that AbbVie argues enables covered entities to claim 340B discounts for minimal or unrelated patient contact.
  • AbbVie is pressing for a narrower patient definition tied to recent, substantive care managed at 340B facility.
  • Company framed action as effort to curb alleged abuse that it says raises overall healthcare costs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief on April 08, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.